mTOR: taking cues from the immune microenvironment

被引:88
作者
Delgoffe, Greg M. [1 ]
Powell, Jonathan D. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
基金
美国国家卫生研究院;
关键词
anergy; dendritic cells; mammalian target of rapamycin; regulatory T cell; T cell; REGULATORY T-CELLS; CONDITIONED DENDRITIC CELLS; MAMMALIAN TARGET; CYCLE PROGRESSION; CLONAL ANERGY; EFFECTOR FUNCTION; IN-VIVO; RAPAMYCIN; INDUCTION; TOLERANCE;
D O I
10.1111/j.1365-2567.2009.03125.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>The ultimate outcome of T cell receptor recognition is determined by the context in which the antigen is encountered. In this fashion both antigen-presenting cells and T cells must integrate multiple environmental cues in the form of pathogen-associated molecular patterns, cytokines and accessory molecule signals. The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase that plays a central role in integrating environmental signals critical to regulating metabolism and cell survival. In this paper we review the data demonstrating that mTOR integrates signals from the immune microenvironment and therefore facilitates the generation of the adaptive immune response. Specifically, we review the role of mTOR in promoting dendritic cell activation and maturation, in regulating full T cell activation versus anergy, and influencing the induction of regulatory T cells.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 65 条
[1]   Immunopharmacology of rapamycin [J].
Abraham, RT ;
Wiederrecht, GJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :483-510
[2]   The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction [J].
Allen, A ;
Zheng, Y ;
Gardner, L ;
Safford, M ;
Horton, MR ;
Powell, JD .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4797-4803
[3]   CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression [J].
Appleman, LJ ;
Berezovskaya, A ;
Grass, I ;
Boussiotis, VA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :144-151
[4]   Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin [J].
Basu, Samik ;
Golovina, Tatiana ;
Mikheeva, Tatiana ;
June, Carl H. ;
Riley, James L. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (09) :5794-5798
[5]   Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells [J].
Battaglia, M ;
Stabilini, A ;
Roncarolo, MG .
BLOOD, 2005, 105 (12) :4743-4748
[6]   Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients [J].
Battaglia, Manuela ;
Stabilini, Angela ;
Migliavacca, Barbara ;
Horejs-Hoeck, Jutta ;
Kaupper, Thomas ;
Roncarolo, Maria-Grazia .
JOURNAL OF IMMUNOLOGY, 2006, 177 (12) :8338-8347
[7]   The two TORCs and Akt [J].
Bhaskar, Prashanth T. ;
Hay, Nissim .
DEVELOPMENTAL CELL, 2007, 12 (04) :487-502
[8]   A THEORY OF SELF-NONSELF DISCRIMINATION [J].
BRETSCHER, P ;
COHN, M .
SCIENCE, 1970, 169 (3950) :1042-+
[9]   Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3) K-mTOR-p70S6K pathway [J].
Cao, Weiping ;
Manicassamy, Santhakumar ;
Tang, Hua ;
Kasturi, Sudhir Pai ;
Pirani, Ali ;
Murthy, Niren ;
Pulendran, Bali .
NATURE IMMUNOLOGY, 2008, 9 (10) :1157-1164
[10]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886